.webp)
Most people with Crohn's disease or ulcerative colitis have been told their condition is an autoimmune problem. And that is true, as far as it goes. But there is a layer that conventional IBD workups almost never look at: the role of active infections in driving and sustaining gut inflammation. Bacteria, viruses, yeast, and parasites can all act as hidden triggers in IBD, keeping the immune system activated even when everything else looks controlled.
In adult functional medicine, testing for infections is one of the first things a thorough IBD workup includes, because chronic gut infections are both common and commonly missed by standard labs. The point is not to throw every tool at the problem at once. The point is to actually find what is there before deciding how to treat it.
The connection between infections and IBD runs in both directions. Certain infections can trigger IBD in people who are genetically predisposed. Once IBD is established, the damaged gut lining and disrupted microbiome create an environment where infections are more likely to take hold and harder to clear. And the immunosuppressive medications used to manage IBD can reduce the body's ability to fight off pathogens, making infections both more common and potentially more serious.
The practical problem is that many gut infections produce symptoms that look exactly like an IBD flare: increased stool frequency, cramping, pain, urgency, fatigue, and elevated inflammatory markers. Without testing specifically for infections, there is no way to know whether what looks like a flare is actually a flare, an active infection, or both at the same time.
Treating an infection with IBD medications, or escalating immunosuppression without knowing an infection is present, can make things significantly worse. This is why systematic infection testing is not optional in a thorough IBD workup. It is foundational.
Bacterial infections and bacterial overgrowth are among the most common and most clinically relevant findings in people with IBD. Standard stool cultures from a gastroenterology workup test for a narrow range of pathogens. Comprehensive functional medicine stool testing looks at a much broader picture.
C. diff is one of the most serious bacterial infections seen in IBD patients, particularly those on long-term antibiotics or immunosuppressants. It causes severe colitis that can be difficult to distinguish from a UC or Crohn's flare on clinical symptoms alone. C. diff testing should be included in every IBD patient workup during active symptoms, and many functional medicine providers test for it routinely even between flares, since subclinical colonization can contribute to ongoing gut dysfunction.
SIBO occurs when bacteria that normally live in the large intestine migrate upward and overpopulate the small intestine. It is extremely common in Crohn's disease, particularly in patients who have had surgery or who have strictures that slow intestinal motility. Symptoms of SIBO overlap substantially with IBD symptoms: bloating, cramping, diarrhea, gas, and fatigue.
SIBO is diagnosed through breath testing, which measures hydrogen and methane gas produced by bacteria fermenting a sugar substrate. Lactulose and glucose breath tests are both used, with different sensitivities for detecting overgrowth in different parts of the small intestine. In IBD patients with persistent symptoms despite controlled disease activity on colonoscopy, SIBO is a very common finding.
Helicobacter pylori infection is sometimes found in IBD patients and can complicate the inflammatory picture, particularly in those with upper GI involvement. Comprehensive stool testing also screens for pathogens, including Campylobacter, Salmonella, Shigella, enterotoxigenic E. coli strains, and Yersinia enterocolitica. Yersinia in particular is underappreciated as a potential IBD trigger: it produces ileitis that can mimic Crohn's disease and has been identified as a possible initiating infection in genetically susceptible individuals.
MAP is a controversial but scientifically serious candidate as a contributing pathogen in Crohn's disease. It is the bacterium that causes Johne's disease in cattle, a condition that causes intestinal inflammation closely resembling Crohn's. MAP has been found at higher rates in Crohn's disease patients than in healthy controls in multiple studies. It is slow-growing and difficult to culture, which is why it is often missed on standard testing. Specialized PCR-based testing can detect MAP DNA in blood and tissue samples.
Viruses do not get as much attention as bacteria in IBD discussions, but they are clinically relevant in several important ways.
CMV is probably the most clinically important viral infection in IBD patients. CMV colitis can cause severe flares in people with UC and Crohn's colitis, and it is particularly common in patients on corticosteroids or other immunosuppressants. CMV reactivation inside the gut mucosa can trigger what looks like a steroid-refractory flare. Testing for CMV through tissue biopsy, PCR, or serum CMV antigenemia is standard practice in IBD patients who are not responding to escalating immunosuppression.
EBV, the virus that causes mononucleosis, establishes lifelong latency in immune cells after initial infection. In people who are immunosuppressed, including IBD patients on thiopurines like azathioprine or 6-mercaptopurine, EBV reactivation can cause serious complications including EBV-associated lymphoma. Testing EBV viral load through PCR is recommended in IBD patients on thiopurines who develop unexplained symptoms, enlarged lymph nodes, or persistent fatigue.
Acute viral infections like norovirus and rotavirus can trigger IBD flares in susceptible individuals. In some cases, an acute viral gastroenteritis episode is what sets off the first IBD flare, or breaks a long period of remission. Stool PCR panels that include viral pathogens are now widely available and should be considered during acute symptom presentations in IBD patients.
Fungal dysbiosis is one of the most consistently overlooked findings in IBD patients. The gut mycobiome, the fungal component of the gut microbiome, is disrupted in both Crohn's disease and ulcerative colitis in ways that appear to contribute to inflammation.
Candida species, particularly Candida albicans, are found at elevated levels in IBD patients compared to healthy controls. Candida can transition from a harmless commensal organism to an invasive pathogen when the gut environment shifts, which happens readily in IBD due to damaged mucosal barriers, antibiotic use, high-sugar diets, and immunosuppressive medications.
Candida overgrowth produces symptoms that overlap significantly with IBD: bloating, gas, diarrhea, fatigue, brain fog, and sugar cravings. It also produces compounds that increase intestinal permeability and promote systemic inflammation. Comprehensive stool testing that includes fungal culture and sensitivity can identify Candida overgrowth and guide targeted antifungal treatment.
Anti-Saccharomyces cerevisiae antibodies, known as ASCA, are one of the most specific serum markers for Crohn's disease. Their presence suggests that the gut immune system has been activated by this particular yeast, which is found naturally in fermented foods and in some probiotic products. ASCA testing is part of a standard serological IBD panel and helps distinguish Crohn's from UC. Elevated ASCA levels are associated with more aggressive Crohn's disease behavior and greater risk of surgery.
Parasitic infections are underdiagnosed in IBD patients, partly because standard ova and parasite testing has poor sensitivity for many clinically relevant organisms. PCR-based stool testing is considerably more accurate.
Blastocystis is one of the most common intestinal parasites found on comprehensive stool testing, and it is also one of the most controversial. Some strains appear to be relatively harmless. Others are associated with gut inflammation, altered microbiome composition, and symptoms including diarrhea, cramping, and fatigue that are indistinguishable from IBD activity. In IBD patients with persistent symptoms that are not responding to standard management, finding Blastocystis on stool testing warrants a treatment trial.
Giardia is a waterborne parasite that causes diarrhea, bloating, and malabsorption. It is frequently missed on standard O and P testing because it is shed intermittently and requires multiple samples or PCR testing to reliably detect. In IBD patients, Giardia infection can precipitate flares or cause persistent symptoms that mimic active disease. It responds well to treatment, which makes finding it important.
Cryptosporidium is particularly relevant in IBD patients who are on immunosuppressive therapy, because it can cause severe and prolonged diarrheal illness in immunocompromised hosts. Other parasites, including Dientamoeba fragilis and Entamoeba histolytica, are also worth screening for in IBD patients with persistent symptoms, especially those with a history of travel or exposure to untreated water sources.
Standard hospital stool cultures test for a handful of bacterial pathogens and do a basic O and P exam. That covers a fraction of what matters in IBD. Comprehensive functional medicine stool testing uses DNA-based PCR technology to detect a much wider range of organisms with far greater accuracy.
The GI-MAP test and similar platforms screen simultaneously for:
They also measure markers of gut inflammation, intestinal permeability, immune function, and digestive enzyme activity in the same sample. The result is a comprehensive picture of what is actually happening in the gut environment, not just whether one or two common pathogens are present.
Depending on symptoms and clinical history, additional testing may include SIBO breath testing, serum viral PCR panels for CMV and EBV, organic acids testing to detect yeast overgrowth metabolites, and, in some cases, specialized bloodwork for MAP antibodies.
Finding an infection in an IBD patient changes the clinical picture in important ways. It explains symptoms that were being attributed to disease activity. It identifies a treatable target. And it prevents the mistake of escalating immunosuppression when what the gut actually needs is pathogen clearance.
Treatment depends on what was found:
Supportive therapies used during and after infection clearance may include gut lining repair nutrients, targeted probiotic protocols to rebuild healthy microbial populations, and in some cases adjunctive therapies like ozone therapy for its antimicrobial and tissue-healing properties or hyperbaric oxygen therapy to support recovery in significantly compromised gut tissue.
You may also want to read our related article How Environmental Toxins Like Pfas And Microplastics Are Disrupting Your Hormones And Health to understand their impact.
If you have Crohn's disease or ulcerative colitis and your symptoms are not fully explained by your current diagnosis and treatment plan, 417 Integrative Medicine in Springfield, Missouri, offers comprehensive infection testing as part of a full functional medicine IBD workup. We use PCR-based stool analysis, SIBO breath testing, viral PCR panels, and specialized bloodwork to build a complete picture of what is driving your gut inflammation.
In adult functional medicine, this level of testing is standard practice, not an afterthought. Finding a hidden infection often changes the entire treatment direction, and that is exactly the kind of clarity that makes a real difference for people who have been struggling without answers.
Reach out to 417 Integrative Medicine to schedule a consultation and get started.
